FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170309844> ?p ?o ?g. }

• W2170309844 endingPage "380" @default.
• W2170309844 startingPage "374" @default.
• W2170309844 abstract "To obtain benzomorphans with a longer duration of action that may be potential therapeutics for treating cocaine abuse, 8-carboxamidocyclazocine was synthesized. The pharmacological properties of 8-carboxamidocyclazocine were compared with the parent compound cyclazocine. Changing the 8-hydroxyl group on cyclazocine to an 8-carboxamido group resulted in only a 2-fold decrease in the affinity of the compound for the kappa-receptor, and no change in the affinity for the mu-opioid receptor, with both compounds having K(i) values of less than 1 nM, based on radioligand binding assays. In the guanosine 5'-O -(3-[(35)S]thio)triphosphate ([(35)S]GTPgammaS) binding assay, the two compounds produced moderate stimulation of GTP binding to the human kappa- and mu-receptors. When given by i.c.v. injection, the compounds produced less than 60% antinociception in the mouse 55 degrees C warm-water tail-flick test. However, in the mouse writhing test, the compounds had high potency in producing antinociception. Antinociception induced by either 8-carboxamidocyclazocine or cyclazocine was mediated by both kappa- and mu-opioid receptors. Cyclazocine acted as a mu-antagonist in addition to its agonist properties at the mu-receptor, as measured by the inhibition of morphine-induced antinociception. In contrast, 8-carboxamidocyclazocine did not inhibit morphine-induced antinociception, demonstrating that it was not a mu-opioid receptor antagonist in this assay. An i.p. injection of an ED(70) dose of 8-carboxamidocyclazocine produced antinociception that lasted for 15 h in contrast to cyclazocine, which produced antinociception, lasting 2 h. 8-Carboxamidocyclazocine is a novel, long-acting benzomorphan, which possesses pharmacological properties that are distinct from the properties of cyclazocine." @default.
• W2170309844 created "2016-06-24" @default.
• W2170309844 creator A5000902500 @default.
• W2170309844 creator A5001580309 @default.
• W2170309844 creator A5027117921 @default.
• W2170309844 creator A5054767297 @default.
• W2170309844 creator A5059513018 @default.
• W2170309844 creator A5090307804 @default.
• W2170309844 date "2002-07-01" @default.
• W2170309844 modified "2023-09-23" @default.
• W2170309844 title "8-Carboxamidocyclazocine: A Long-Acting, Novel Benzomorphan" @default.
• W2170309844 cites W113553104 @default.
• W2170309844 cites W1968230377 @default.
• W2170309844 cites W1972873401 @default.
• W2170309844 cites W1975904615 @default.
• W2170309844 cites W1976808064 @default.
• W2170309844 cites W1979011598 @default.
• W2170309844 cites W1996307302 @default.
• W2170309844 cites W1996704538 @default.
• W2170309844 cites W2010531200 @default.
• W2170309844 cites W2011400889 @default.
• W2170309844 cites W2011645297 @default.
• W2170309844 cites W2017860510 @default.
• W2170309844 cites W2036976678 @default.
• W2170309844 cites W2043813981 @default.
• W2170309844 cites W2048921553 @default.
• W2170309844 cites W2052630265 @default.
• W2170309844 cites W2067020336 @default.
• W2170309844 cites W2070065023 @default.
• W2170309844 cites W2074631079 @default.
• W2170309844 cites W2085960115 @default.
• W2170309844 cites W2094785567 @default.
• W2170309844 cites W2133672910 @default.
• W2170309844 cites W2165398609 @default.
• W2170309844 cites W2506121317 @default.
• W2170309844 cites W2949502229 @default.
• W2170309844 cites W3190882221 @default.
• W2170309844 doi "https://doi.org/10.1124/jpet.302.1.374" @default.
• W2170309844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12065740" @default.
• W2170309844 hasPublicationYear "2002" @default.
• W2170309844 type Work @default.
• W2170309844 sameAs 2170309844 @default.
• W2170309844 citedByCount "26" @default.
• W2170309844 countsByYear W21703098442012 @default.
• W2170309844 countsByYear W21703098442013 @default.
• W2170309844 countsByYear W21703098442014 @default.
• W2170309844 countsByYear W21703098442016 @default.
• W2170309844 countsByYear W21703098442018 @default.
• W2170309844 countsByYear W21703098442019 @default.
• W2170309844 countsByYear W21703098442020 @default.
• W2170309844 countsByYear W21703098442021 @default.
• W2170309844 countsByYear W21703098442022 @default.
• W2170309844 crossrefType "journal-article" @default.
• W2170309844 hasAuthorship W2170309844A5000902500 @default.
• W2170309844 hasAuthorship W2170309844A5001580309 @default.
• W2170309844 hasAuthorship W2170309844A5027117921 @default.
• W2170309844 hasAuthorship W2170309844A5054767297 @default.
• W2170309844 hasAuthorship W2170309844A5059513018 @default.
• W2170309844 hasAuthorship W2170309844A5090307804 @default.
• W2170309844 hasConcept C14397066 @default.
• W2170309844 hasConcept C170493617 @default.
• W2170309844 hasConcept C184389661 @default.
• W2170309844 hasConcept C185592680 @default.
• W2170309844 hasConcept C2776885963 @default.
• W2170309844 hasConcept C2777389121 @default.
• W2170309844 hasConcept C2777972943 @default.
• W2170309844 hasConcept C2778684643 @default.
• W2170309844 hasConcept C2778750930 @default.
• W2170309844 hasConcept C2778938600 @default.
• W2170309844 hasConcept C2779886867 @default.
• W2170309844 hasConcept C2781063702 @default.
• W2170309844 hasConcept C55493867 @default.
• W2170309844 hasConcept C67847695 @default.
• W2170309844 hasConcept C71240020 @default.
• W2170309844 hasConcept C71924100 @default.
• W2170309844 hasConcept C98274493 @default.
• W2170309844 hasConceptScore W2170309844C14397066 @default.
• W2170309844 hasConceptScore W2170309844C170493617 @default.
• W2170309844 hasConceptScore W2170309844C184389661 @default.
• W2170309844 hasConceptScore W2170309844C185592680 @default.
• W2170309844 hasConceptScore W2170309844C2776885963 @default.
• W2170309844 hasConceptScore W2170309844C2777389121 @default.
• W2170309844 hasConceptScore W2170309844C2777972943 @default.
• W2170309844 hasConceptScore W2170309844C2778684643 @default.
• W2170309844 hasConceptScore W2170309844C2778750930 @default.
• W2170309844 hasConceptScore W2170309844C2778938600 @default.
• W2170309844 hasConceptScore W2170309844C2779886867 @default.
• W2170309844 hasConceptScore W2170309844C2781063702 @default.
• W2170309844 hasConceptScore W2170309844C55493867 @default.
• W2170309844 hasConceptScore W2170309844C67847695 @default.
• W2170309844 hasConceptScore W2170309844C71240020 @default.
• W2170309844 hasConceptScore W2170309844C71924100 @default.
• W2170309844 hasConceptScore W2170309844C98274493 @default.
• W2170309844 hasIssue "1" @default.
• W2170309844 hasLocation W21703098441 @default.
• W2170309844 hasLocation W21703098442 @default.
• W2170309844 hasOpenAccess W2170309844 @default.
• W2170309844 hasPrimaryLocation W21703098441 @default.

• next